Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.
Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, Chanswangphuwana C, Efebera YA, Holler E, Litzow M, Ordemann R, Qayed M, Renteria AS, Reshef R, Wölfl M, Chen YB, Goldstein S, Jagasia M, Locatelli F, Mielke S, Porter D, Schechter T, Shekhovtsova Z, Ferrara JL, Levine JE. Harris AC, et al. Among authors: chen yb. Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10. doi: 10.1016/j.bbmt.2015.09.001. Epub 2015 Sep 16. Biol Blood Marrow Transplant. 2016. PMID: 26386318 Free PMC article.
Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Chen YB, Kim HT, McDonough S, Odze RD, Yao X, Lazo-Kallanian S, Spitzer TR, Soiffer R, Antin JH, Ritz J. Chen YB, et al. Biol Blood Marrow Transplant. 2009 Sep;15(9):1066-76. doi: 10.1016/j.bbmt.2009.05.003. Epub 2009 Jul 8. Biol Blood Marrow Transplant. 2009. PMID: 19660719 Free PMC article.
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
Ulrickson M, Aldridge J, Kim HT, Hochberg EP, Hammerman P, Dube C, Attar E, Ballen KK, Dey BR, McAfee SL, Spitzer TR, Chen YB. Ulrickson M, et al. Among authors: chen yb. Biol Blood Marrow Transplant. 2009 Nov;15(11):1447-54. doi: 10.1016/j.bbmt.2009.07.014. Epub 2009 Sep 1. Biol Blood Marrow Transplant. 2009. PMID: 19822305 Free article.
Donor-derived second hematologic malignancies after cord blood transplantation.
Ballen KK, Cutler C, Yeap BY, McAfee SL, Dey BR, Attar EC, Chen YB, Haspel RL, Liney D, Koreth J, Ho V, Alyea EP, Soiffer RJ, Spitzer TR, Antin JH. Ballen KK, et al. Among authors: chen yb. Biol Blood Marrow Transplant. 2010 Jul;16(7):1025-31. doi: 10.1016/j.bbmt.2010.02.014. Epub 2010 Feb 21. Biol Blood Marrow Transplant. 2010. PMID: 20178854 Free PMC article.
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.
Cote GM, Hochberg EP, Muzikansky A, Hochberg FH, Drappatz J, McAfee SL, Batchelor TT, LaCasce AS, Fisher DC, Abramson JS, Armand P, Chen YB. Cote GM, et al. Among authors: chen yb. Biol Blood Marrow Transplant. 2012 Jan;18(1):76-83. doi: 10.1016/j.bbmt.2011.07.006. Epub 2011 Jul 13. Biol Blood Marrow Transplant. 2012. PMID: 21749848 Free article.
Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.
Jacobson CA, Turki AT, McDonough SM, Stevenson KE, Kim HT, Kao G, Herrera MI, Reynolds CG, Alyea EP, Ho VT, Koreth J, Armand P, Chen YB, Ballen K, Soiffer RJ, Antin JH, Cutler CS, Ritz J. Jacobson CA, et al. Among authors: chen yb. Biol Blood Marrow Transplant. 2012 Apr;18(4):565-74. doi: 10.1016/j.bbmt.2011.08.018. Epub 2011 Aug 26. Biol Blood Marrow Transplant. 2012. PMID: 21875503 Free PMC article.
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.
Chen YB, Aldridge J, Kim HT, Ballen KK, Cutler C, Kao G, Liney D, Bourdeau G, Alyea EP, Armand P, Koreth J, Ritz J, Spitzer TR, Soiffer RJ, Antin JH, Ho VT. Chen YB, et al. Biol Blood Marrow Transplant. 2012 May;18(5):805-12. doi: 10.1016/j.bbmt.2011.10.016. Epub 2011 Oct 19. Biol Blood Marrow Transplant. 2012. PMID: 22015993 Free article.
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era.
Warlick E, Ahn KW, Pedersen TL, Artz A, de Lima M, Pulsipher M, Akpek G, Aljurf M, Cahn JY, Cairo M, Chen YB, Cooper B, Deol A, Giralt S, Gupta V, Khoury HJ, Kohrt H, Lazarus HM, Lewis I, Olsson R, Pidala J, Savani BN, Seftel M, Socié G, Tallman M, Ustun C, Vij R, Vindeløv L, Weisdorf D. Warlick E, et al. Among authors: chen yb. Blood. 2012 Apr 26;119(17):4083-90. doi: 10.1182/blood-2012-02-409763. Epub 2012 Mar 9. Blood. 2012. PMID: 22408257 Free PMC article.
Expression of CD30 in patients with acute graft-versus-host disease.
Chen YB, McDonough S, Hasserjian R, Chen H, Coughlin E, Illiano C, Park IS, Jagasia M, Spitzer TR, Cutler CS, Soiffer RJ, Ritz J. Chen YB, et al. Among authors: chen h. Blood. 2012 Jul 19;120(3):691-6. doi: 10.1182/blood-2012-03-415422. Epub 2012 Jun 1. Blood. 2012. PMID: 22661699 Free PMC article.
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
Chen YB, Coughlin E, Kennedy KF, Alyea EP, Armand P, Attar EC, Ballen KK, Cutler C, Dey BR, Koreth J, McAfee SL, Spitzer TR, Antin JH, Soiffer RJ, Ho VT. Chen YB, et al. Biol Blood Marrow Transplant. 2013 Jun;19(6):981-7. doi: 10.1016/j.bbmt.2013.03.016. Epub 2013 Apr 2. Biol Blood Marrow Transplant. 2013. PMID: 23562738 Free article.
1,208 results